Abstract:This review highlights the treatment of osteoarthritis through intra‐articular injection of nanomaterials, focusing on material therapy (polymer brush, nanocomposite hydrogel, and nanoparticle), cell therapy (mesenchymal stem cells and their exosomes), and gene therapy (microRNA, siRNA, and other non‐coding RNA). It details the multifaceted roles of these nanomaterials in lubrication, anti‐inflammation, targeting, cartilage repair, and drug delivery. Osteoarthritis (OA), a prevalent joint disease affecting many people globally, presents significant challenge in current treatments, which often only manage symptoms without halting disease progression. This review illuminates novel approaches in OA therapy, focusing mainly on intra‐articular injection of nanomaterials. The innovative materials, designed to either mimic or augment natural joint lubrication, show promise in restoring joint biomechanics and alleviating pain. The review delves into an array of biomimetic lubricants, including polymer brush, nanocomposite hydrogel, and nanoparticles, underscoring their roles in anti‐inflammation, targeting, cartilage repair, and drug delivery. Furthermore, the potential of mesenchymal stem cells to differentiate into chondrocytes, coupled with the delivery of these cells and their exosomes via nanomaterials, has promoted cell therapy avenues for OA. The review also highlights the function of non‐coding RNAs such as miRNA, siRNA, circRNA, lncRNA, and antisense oligonucleotides in impeding OA progression, with nanomaterials facilitating their delivery, thus facilitating advanced therapeutic possibilities including immune evasion and bone cell proliferation. Overall, this review encapsulates the evolution of nanomaterials in OA treatment from material to cell, and ultimately to gene therapy, forecasting a future where nanomaterials evolve toward integrated, personalized diagnostics and therapeutics for OA.

Advancements in pH-Responsive nanoparticles for osteoarthritis treatment: Opportunities and challenges

Advanced nanoparticles in osteoarthritis treatment

Stimuli-Sensitive Nanotherapies for the Treatment of Osteoarthritis

Microenvironment-responsive Nanosystems for Osteoarthritis Therapy

Nanoparticle-Based Drug Delivery System—A Target Strategy for Osteoarthritis Treatment

Advancements in Inflammation Control and Cartilage Regeneration

Therapeutic potential of nanotechnology-based approaches in osteoarthritis

Nanomaterials: Recent Advances in Knee Osteoarthritis Treatment

Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management

Intra-articular Nanodrug Delivery Strategies for Treating Osteoarthritis.

Nanoparticle–Cartilage Interaction: Pathology-Based Intra-articular Drug Delivery for Osteoarthritis Therapy

A review focusing on the benefits of plant-derived polysaccharides for osteoarthritis

Targeted and responsive biomaterials in osteoarthritis

Controlled Stimulus-Responsive Delivery Systems for Osteoarthritis Treatment

Targeted treatment for osteoarthritis: drugs and delivery system

Progress and Challenges of Topical Delivery Technologies Meditated Drug Therapy for Osteoarthritis

A Composite Nanomaterial with the Ability to Regulate Oxidative Stress and Anti‐inflammatory for the Treatment of Osteoarthritis

[Research Progress of Nanomaterials for Intra-Articular Targeted Drug Delivery in Treatment of Osteoarthritis].

A pH-responsive mesoporous silica nanoparticles-based drug delivery system with controlled release of andrographolide for OA treatment

Intra‐Articular Injection of Nanomaterials for the Treatment of Osteoarthritis: From Lubrication Function Restoration to Cell and Gene Therapy

Small molecule inhibitors of osteoarthritis: Current development and future perspective